Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-11-049272)

Filing Details

Accession Number:: 0001144204-11-049272
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-23 08:39:12
Reporting Period:: 2011-08-19

Filing Date:: 2011-08-23
Accepted Time:: 2011-08-23 08:39:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
811641	Immucell Corp	ICCC	In Vitro & In Vivo Diagnostic Substances (2835)	010382980

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1384044	Scott David Tomsche	C/O Immucell Corporation 56 Evergreen Drive Portland ME US 04103		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.10 Per Share	Acquisiton	2011-08-19	15,000	$5.80	52,668	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Options (Right to Buy)	Disposition	2011-08-19	15,000	$0.00	15,000	$5.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2011-12-20	No	4	X	Direct

Footnotes

Exercisable as to 5,000 shares on and after June 8, 2007 and an additional 5,000 shares on and after June 7, 2008 and the remaining 5,000 shares on and after June 13, 2009.